Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and related conditions in adults.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions. - Gastro‑oesophageal reflux disease (GERD): relieves heartburn and promotes healing of esophageal irritation. - Erosive oesophagitis: reduces acid exposure to allow mucosal recovery. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - NSAID‑induced gastric ulcer prevention: lowers ulcer risk in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach area. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: severe colitis associated with antibiotic use. - Hypomagnesemia: low magnesium levels that may cause muscle cramps or cardiac issues. - Vitamin B12 deficiency: potential long‑term deficiency affecting blood cells. - Bone fractures: increased risk with prolonged use. - Elevated liver enzymes: signs of hepatic stress.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate for CYP2C19 interactions: esomeprazole metabolism may be affected. - Monitor magnesium levels: especially during long‑term treatment. - Use with caution in the elderly: higher incidence of adverse events. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Store at room temperature: keep in the original pack, protect from moisture.

Esomeprazole may alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet effect. - Warfarin: potential increase in anticoagulant activity. - HIV protease inhibitors: altered antiviral levels.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentration. - Phenytoin: reduced anticonvulsant levels. - Rifampin: decreased esomeprazole exposure. - Methotrexate: increased toxicity risk. - Diazepam: enhanced sedative effect.